Literature DB >> 6423079

Drug resistance in Shigella dysenteriae, S flexneri and S boydii in England and Wales: increasing incidence of resistance to trimethoprim.

R J Gross, E J Threlfall, L R Ward, B Rowe.   

Abstract

A total of 2753 strains of shigella belonging to subgroups A, B, and C that were isolated from patients in England and Wales during the period from 1979 to mid-1983 were studied. Of these, 1690 (61%) were from patients recently returned from abroad or in contact with recent travellers, and 760 (45%) of these affected travellers from the Indian subcontinent. The number of strains resistant to sulphonamides and streptomycin remained at a high level throughout (average 76% and 72% respectively). Resistance to tetracyclines, ampicillin, and chloramphenicol rose, reaching 63%, 51%, and 48%, respectively, in 1982. Strains resistant to trimethoprim were seen in substantial numbers for the first time and increased from 1.3% of all strains in 1979 to 9.9% in 1982 and 16.8% in the first half of 1983. The proportion of patients with recent foreign contact was notably smaller among those with strains resistant to trimethoprim than among those with strains sensitive to trimethoprim. The increase in resistance to trimethoprim might partly result from the use in Britain of compounds containing trimethoprim for the treatment of shigellosis.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6423079      PMCID: PMC1444629          DOI: 10.1136/bmj.288.6419.784

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


  11 in total

1.  Agar plate dilution method for routine antibiotic susceptibility testing in a hospital laboratory.

Authors:  K C Haltalin; A H Markley; E Woodman
Journal:  Am J Clin Pathol       Date:  1973-09       Impact factor: 2.493

2.  Letter: Ampicillin-resistant Shiga bacillus in Bangladesh.

Authors:  M M Rahaman; I Huo; C R Dey; A K Kibriya; G Curlin
Journal:  Lancet       Date:  1974-03-09       Impact factor: 79.321

3.  Impact in the United States of the Shiga dysentery pandemic of Central America and Mexico: a review of surveillance data through 1972.

Authors:  J B Weissman; K I Marton; J N Lewis; C T Friedmann; E J Gangarosa
Journal:  J Infect Dis       Date:  1974-02       Impact factor: 5.226

4.  Epidemic Shiga bacillus dysentery in Central America. II. Epidemiologic studies in 1969.

Authors:  E J Gangarosa; D R Perera; L J Mata; C Mendizábal-Morris; G Guzmán; L B Reller
Journal:  J Infect Dis       Date:  1970-09       Impact factor: 5.226

5.  A rapid screening test for transfer factors in drug-sensitive Enterobacteriaceae.

Authors:  E S Anderson
Journal:  Nature       Date:  1965-12-04       Impact factor: 49.962

6.  Characterization of a transfer factor associated with drug resistance in Salmonella typhimurium.

Authors:  E S Anderson; M J Lewis
Journal:  Nature       Date:  1965-11-27       Impact factor: 49.962

7.  Acquisition of trimethoprim resistance in epidemic strain of Shigella dysenteriae type 1 from Zaire.

Authors:  J A Frost; B Rowe; J Vandepitte
Journal:  Lancet       Date:  1982-04-24       Impact factor: 79.321

8.  Plasmid characterisation in the investigation of an epidemic caused by multiply resistant Shigella dysenteriae type 1 in Central Africa.

Authors:  J A Frost; B Rowe; J Vandepitte; E J Threlfall
Journal:  Lancet       Date:  1981-11-14       Impact factor: 79.321

9.  Increase in drug resistance among Shigella dysenteriae, Sh flexneri, and Sh boydii.

Authors:  R J Gross; B Rowe; T Cheasty; L V Thomas
Journal:  Br Med J (Clin Res Ed)       Date:  1981-08-29

10.  In vitro contracture tests for susceptibility to malignant hyperthermia.

Authors:  H Rosenberg; S Reed
Journal:  Anesth Analg       Date:  1983-04       Impact factor: 5.108

View more
  10 in total

Review 1.  [Progress in oral antibiotic therapy in practice].

Authors:  H E Pichler
Journal:  Infection       Date:  1991       Impact factor: 3.553

2.  Microbiological laboratory results from Haiti: June-October 1995.

Authors:  J J Drabick; J M Gambel; E Huck; S De Young; L Hardeman
Journal:  Bull World Health Organ       Date:  1997       Impact factor: 9.408

3.  Susceptibilities of Hong Kong isolates of multiply resistant Shigella spp. to 25 antimicrobial agents, including ampicillin plus sulbactam and new 4-quinolones.

Authors:  J Ling; K M Kam; A W Lam; G L French
Journal:  Antimicrob Agents Chemother       Date:  1988-01       Impact factor: 5.191

Review 4.  Trimethoprim and sulfonamide resistance.

Authors:  P Huovinen; L Sundström; G Swedberg; O Sköld
Journal:  Antimicrob Agents Chemother       Date:  1995-02       Impact factor: 5.191

5.  Comparison of single-dose treatment with norfloxacin and standard 5-day treatment with trimethoprim-sulfamethoxazole for acute shigellosis in adults.

Authors:  E Gotuzzo; R A Oberhelman; C Maguiña; S J Berry; A Yi; M Guzman; R Ruiz; R Leon-Barua; R B Sack
Journal:  Antimicrob Agents Chemother       Date:  1989-07       Impact factor: 5.191

6.  Molecular characterization of trimethoprim resistance in Shigella sonnei in Sicily.

Authors:  A Agodi; C Jones; E J Threlfall; M D'Angelo; M Marranzano
Journal:  Epidemiol Infect       Date:  1990-08       Impact factor: 2.451

7.  Comparison of norfloxacin and nalidixic acid for treatment of dysentery caused by Shigella dysenteriae type 1 in adults.

Authors:  F Rogerie; D Ott; J Vandepitte; L Verbist; P Lemmens; I Habiyaremye
Journal:  Antimicrob Agents Chemother       Date:  1986-05       Impact factor: 5.191

8.  The comparative activity of pefloxacin, enoxacin, ciprofloxacin and 13 other antimicrobial agents against enteropathogenic microorganisms.

Authors:  R Vanhoof; J M Hubrechts; E Roebben; H J Nyssen; E Nulens; J Leger; N De Schepper
Journal:  Infection       Date:  1986 Nov-Dec       Impact factor: 3.553

Review 9.  Use of quinolones in the treatment of gastrointestinal infections.

Authors:  H L DuPont
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1991-04       Impact factor: 3.267

10.  Comparative in vitro activity of ceftibuten (Sch 39720) against bacterial enteropathogens.

Authors:  R Shawar; M LaRocco; T G Cleary
Journal:  Antimicrob Agents Chemother       Date:  1989-05       Impact factor: 5.191

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.